Clariane SE (CLARI.PA)
EUR 3.88
(1.89%)
EUR 3.88
(1.89%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 907.47 Million EUR | 1.08% |
| 2022 | 907.45 Million EUR | -2.84% |
| 2021 | 841.75 Million EUR | 20.63% |
| 2020 | 760.02 Million EUR | -1.95% |
| 2019 | 884.89 Million EUR | 88.65% |
| 2018 | 467.14 Million EUR | 4.14% |
| 2017 | 433.83 Million EUR | 19.81% |
| 2016 | 386.01 Million EUR | 16.4% |
| 2015 | 313.41 Million EUR | -1.71% |
| 2014 | 303.08 Million EUR | 86.07% |
| 2013 | 163.08 Million EUR | 47.61% |
| 2012 | 125.41 Million EUR | 1.22% |
| 2011 | 113.85 Million EUR | 5.42% |
| 2010 | 106.16 Million EUR | 21.33% |
| 2009 | 89.01 Million EUR | -6.4% |
| 2008 | 95.15 Million EUR | 15.79% |
| 2007 | 82.12 Million EUR | 27.2% |
| 2006 | 75.86 Million EUR | -6.36% |
| 2005 | 68.74 Million EUR | 107.47% |
| 2004 | 33.23 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 124.74 Million EUR | -12.75% |
| 2024 Q1 | 142.97 Million EUR | -64.99% |
| 2023 FY | - EUR | 1.08% |
| 2023 Q1 | 212.87 Million EUR | -58.44% |
| 2023 Q4 | 528.99 Million EUR | 174.65% |
| 2023 Q3 | 192.6 Million EUR | -58.22% |
| 2023 Q2 | 461.01 Million EUR | 116.57% |
| 2022 Q3 | 264.76 Million EUR | -46.08% |
| 2022 Q1 | 188.96 Million EUR | -64.65% |
| 2022 FY | - EUR | -2.84% |
| 2022 Q4 | 512.16 Million EUR | 93.44% |
| 2022 Q2 | 491.06 Million EUR | 159.88% |
| 2021 Q4 | 534.57 Million EUR | 309.35% |
| 2021 Q3 | 130.59 Million EUR | -72.52% |
| 2021 Q2 | 475.27 Million EUR | 155.76% |
| 2021 Q1 | 185.82 Million EUR | -59.06% |
| 2021 FY | - EUR | 20.63% |
| 2020 Q2 | 407.25 Million EUR | 124.87% |
| 2020 FY | - EUR | -1.95% |
| 2020 Q3 | 198.9 Million EUR | -51.16% |
| 2020 Q4 | 453.86 Million EUR | 128.18% |
| 2020 Q1 | 181.1 Million EUR | -60.16% |
| 2019 FY | - EUR | 88.65% |
| 2019 Q4 | 454.56 Million EUR | 92.63% |
| 2019 Q3 | 235.97 Million EUR | -45.16% |
| 2019 Q2 | 430.33 Million EUR | 108.42% |
| 2019 Q1 | 206.47 Million EUR | 68.37% |
| 2018 Q3 | 122.63 Million EUR | 10.54% |
| 2018 FY | - EUR | 4.14% |
| 2018 Q1 | 110.94 Million EUR | -6.33% |
| 2018 Q4 | 122.63 Million EUR | 0.0% |
| 2018 Q2 | 110.94 Million EUR | 0.0% |
| 2017 FY | - EUR | 19.81% |
| 2017 Q4 | 118.43 Million EUR | 0.0% |
| 2017 Q3 | 118.43 Million EUR | 16.72% |
| 2017 Q2 | 101.47 Million EUR | 0.0% |
| 2017 Q1 | 101.47 Million EUR | 0.86% |
| 2016 Q3 | 100.6 Million EUR | 4.06% |
| 2016 Q4 | 100.6 Million EUR | 0.0% |
| 2016 FY | - EUR | 16.4% |
| 2016 Q1 | 96.67 Million EUR | 39.84% |
| 2016 Q2 | 96.67 Million EUR | 0.0% |
| 2015 Q1 | 83.67 Million EUR | -10.26% |
| 2015 Q4 | 69.13 Million EUR | 0.0% |
| 2015 Q3 | 69.13 Million EUR | -17.37% |
| 2015 Q2 | 83.67 Million EUR | 0.0% |
| 2015 FY | - EUR | -1.71% |
| 2014 Q3 | 93.23 Million EUR | 67.37% |
| 2014 Q4 | 93.23 Million EUR | 0.0% |
| 2014 FY | - EUR | 86.07% |
| 2014 Q1 | 55.7 Million EUR | 17.45% |
| 2014 Q2 | 55.7 Million EUR | 0.0% |
| 2013 Q2 | 36.91 Million EUR | 0.0% |
| 2013 FY | - EUR | 47.61% |
| 2013 Q4 | 47.43 Million EUR | 0.0% |
| 2013 Q3 | 47.43 Million EUR | 28.48% |
| 2013 Q1 | 36.91 Million EUR | 0.0% |
| 2012 FY | - EUR | 1.22% |
| 2011 FY | - EUR | 5.42% |
| 2010 FY | - EUR | 21.33% |
| 2009 FY | - EUR | -6.4% |
| 2008 FY | - EUR | 15.79% |
| 2007 FY | - EUR | 27.2% |
| 2006 FY | - EUR | -6.36% |
| 2005 FY | - EUR | 107.47% |
| 2004 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ramsay Générale de Santé SA | 565.1 Million EUR | -60.587% |
| LNA Santé SA | 144.63 Million EUR | -527.426% |